ArticlePloS one2012

Combined Inhibition of IGF-1R/IR and Src family kinases enhances antitumor effects in prostate cancer by decreasing activated survival pathways.

Farshid Dayyani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.